SC 13G

Company

Ernexa Therapeutics Inc.

Filed

October 12, 2017

Accession Number

0001062993-17-004416

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →